Metabolic Reprogramming of T Cells by Dual UCP2 and IL‐17 Blockade Enhances Immunity Against Pancreatic Cancer (Adv. Sci. 16/2026)
Year: 2026
Type: article
Source: Advanced Science
DOI: 10.1002/advs.74554
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $6,730
OpenAlex ID: W7139101473
